Cytoprotective Effects of a Novel Nrf2 Activator, RS9, in Rhodopsin Pro347Leu Rabbits
- 2 October 2015
- journal article
- Published by Taylor & Francis in Current Eye Research
- Vol. 41 (8) , 1123-1126
Abstract
Purpose: Rhodopsin Pro347Leu transgenic rabbits were previously generated as models of retinitis pigmentosa (RP). While the mechanism underlying the retinal deterioration in these rabbits remains unresolved, it is likely that oxidative stress is one of the factors triggering cellular loss. We have recently succeeded in obtaining a novel activator (RS9) of nuclear factor erythroid 2-related factor (Nrf2, also known as NFE2L2), which regulates antioxidant transcriptional factors. The purpose of this study was to investigate whether RS9 delays progressive retinal degeneration in the transgenic rabbits. Methods: RS9 microspheres (3 mM, 50 µL) were injected into the vitreous of rhodopsin Pro347Leu transgenic rabbits at 6 weeks, after which outer nuclear layer (ONL) thickness was measured by optical coherence tomography. Rabbits were sacrificed at 15 weeks. Results: After intravitreal injection of RS9 microspheres, the concentration of RS9 in the vitreous was maintained at 1 nM for 2 weeks. At a concentration of 0.3 mM and 50 µL, RS9 significantly inhibited thinning of the ONL in transgenic rabbits compared to vehicle-injected transgenic rabbits. In RS9-injected transgenic rabbits, Nrf2-targeted genes had increased significantly, and levels of interleukin-6 mRNA decreased. Conclusions: Activation of Nrf2 signaling has potential as a novel approach for the prevention and treatment of RP, not only by driving intrinsic antioxidant enzymes, but also by inhibiting inflammatory responses. Although microspheres were employed in this study, small implants that release more compounds might be a realistic method for clinical trials.Keywords
This publication has 12 references indexed in Scilit:
- Redox regulation of antioxidants, autophagy, and the response to stress: Implications for electrophile therapeuticsFree Radical Biology and Medicine, 2014
- Altered Antioxidant-Oxidant Status in the Aqueous Humor and Peripheral Blood of Patients with Retinitis PigmentosaPLOS ONE, 2013
- Transcription Factor Nrf2-Mediated Antioxidant Defense System in the Development of Diabetic RetinopathyInvestigative Ophthalmology & Visual Science, 2013
- Toward clinical application of the Keap1–Nrf2 pathwayTrends in Pharmacological Sciences, 2013
- Photoreceptor and Post-Photoreceptoral Contributions to Photopic ERG a-Wave in Rhodopsin P347L Transgenic RabbitsInvestigative Ophthalmology & Visual Science, 2012
- New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative StressJournal of Natural Products, 2011
- N-acetylcysteine promotes long-term survival of cones in a model of retinitis pigmentosaJournal of Cellular Physiology, 2010
- Increased Expression of Catalase and Superoxide Dismutase 2 Reduces Cone Cell Death in Retinitis PigmentosaMolecular Therapy, 2009
- Generation of a Transgenic Rabbit Model of Retinal DegenerationInvestigative Ophthalmology & Visual Science, 2009
- Gene mutations in retinitis pigmentosa and their clinical implicationsClinica Chimica Acta, 2005